Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Особенности коррекции синдрома спастичности у пациентов с очаговыми повреждениями центральной нервной системы
Особенности коррекции синдрома спастичности у пациентов с очаговыми повреждениями центральной нервной системы
Хатькова С.Е., Акулов М.А., Усачев Д.Ю. и др. Особенности коррекции синдрома спастичности у пациентов с очаговыми повреждениями центральной нервной системы. Consilium Medicum. 2017; 19 (2.1): 25–30.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Очаговое повреждение центральной нервной системы часто приводит к развитию спастического пареза, что значимо нарушает двигательный контроль и снижает качество жизни пациентов. Снижение избыточно повышенного мышечного тонуса при помощи инъекций ботулотоксина типа А и обучение двигательным навыкам являются основой двигательного восстановления. Поэтому ботулинотерапия должна включаться в комплекс реабилитационных мероприятий для снижения мышечного тонуса и создания условий для проведения адекватной двигательной реабилитации. Алгоритм реабилитационных мероприятий для пациентов, перенесших инсульт или черепно-мозговую травму, должен основываться на этапности оказания медицинской помощи и принципе междисциплинарной реабилитации.
Ключевые слова: спастичность, очаговое повреждение центральной нервной системы, острое нарушение мозгового кровообращения, черепно-мозговая травма, ботулинический токсин типа А, реабилитация.
Key words: spasticity, focal lesions of the central nervous system, stroke, traumatic brain injury, botulinum toxin A, rehabilitation.
Ключевые слова: спастичность, очаговое повреждение центральной нервной системы, острое нарушение мозгового кровообращения, черепно-мозговая травма, ботулинический токсин типа А, реабилитация.
________________________________________________
Key words: spasticity, focal lesions of the central nervous system, stroke, traumatic brain injury, botulinum toxin A, rehabilitation.
Полный текст
Список литературы
1. Dong Y, Wu T, Hu X, Wang T. Efficacy and safety of Botulinum Toxin type A for upper limb spasticity after stroke or traumaticbrain injury: a systematic review with meta-analysis and trial sequential analysis. Eur J Phys Rehabil Med 2016. [Epub ahead of print].
2. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31 (5): 535–51.
3. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31 (5): 552–71.
4. Vinti M, Bayle N, Hutin E et al. Stretch-sensitive paresis and effort perception in hemiparesis. J Neural Transm (Vienna) 2015; 122 (8): 1089–97.
5. Gracies JM. Coefficients of impairment in deforming spastic paresis. Ann Phys Rehabil Med 2015; 58 (3): 173–8.
6. Burke D, Gillies JD, Lance JW. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 1970; 33 (2): 216–23.
7. Tardieu G, Shentoub S, Delarue R. Research on a technic for measurement of spasticity. Rev Neurol (Paris) 1954; 91 (2): 143–4.
8. Акулов М.А., Хатькова С.Е., Мокиенко О.А. и др. Эффективность ботулинотерапии в лечении спастичности верхней конечности у пациентов с черепно-мозговой травмой. Журн. неврологии и психиатрии им. C.C.Корсакова. 2016; 116 (8): 30–5. / Akulov M.A., Khat'kova S.E., Mokienko O.A. i dr. Effektivnost' botulinoterapii v lechenii spastichnosti verkhnei konechnosti u patsientov s cherepno-mozgovoi travmoi. Zhurn. nevrologii i psikhiatrii im. C.C.Korsakova. 2016; 116 (8): 30–5. [in Russian]
9. Breceda EY, Dromerick AW. Motor rehabilitation in stroke and traumatic brain injury: stimulating and intense. Curr Opin Neurol 2013; 26 (6): 595–601.
10. Simon O, Yelnik AP. Managingspasticity with drugs. Eur J Phys Rehabil Med 2010; 46 (3): 401–10.
11. Sommerfeld DK, Eek EU, Svensson AK et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35 (1): 134–9.
12. Pattuwage L, Olver J, Martin C et al. Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines. J Head Trauma Rehabil 2016. [Epub ahead of print].
13. Wissel J, Verrier M, Simpson DM et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PMR 2015; 7 (1): 60–7.
14. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009; 8 (8): 741–54.
15. Veerbeek JM, van Wegen E, van Peppen R et al. What is the evidence for physical therapy post stroke? A systematic review and meta-analysis. PLoS One 2014; 9 (2): 879–87.
16. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011; 17 (1): 3–10.
17. Sheean G. Botulinum toxin should be first-line treatment for poststroke spasticity. J Neurol Neurosurg Psychiatry 2009; 80 (4): 359.
18. Simpson DM, Hallett M, Ashman EJ et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016; 86 (19): 1818–26.
19. Wissel J, Ward AB, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41 (1): 13–25.
20. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic Literature Review of AboBoNT-A in Clinical Trials for Lower Limb Spasticity. Medicine (Baltimore) 2016; 95 (2): 24–8.
21. Gracies JM, Esquenazi A, Brashear A et al. Poster 288 Efficacy and Safety of Repeated Abobotulinumtoxin A Injections in Adults with Lower Limb Spasticity. PMR 2016; 8 (9): 254.
22. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007; 5: 132–8.
23. Sheean G., McGuire J.R. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PMR 2009; 1: 827–33.
24. Rosales RL, Kong KH, Goh KJ et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair 2012; 26 (7): 812–21.
25. Хатькова С.Е., Акулов М.А., Орлова О.Р., Орлова А.С. Современные подходы к реабилитации больных после инсульта. Нервные болезни. 2016; 3: 27–33. / Khat'kova S.E., Akulov M.A., Orlova O.R., Orlova A.S. Sovremennye podkhody k reabilitatsii bol'nykh posle insul'ta. Nervnye bolezni. 2016; 3: 27–33. [in Russian]
26. Румянцева С.А., Силина Е.В., Орлова А.С., Болевич С.Б. Оценка реабилитационного потенциала у коморбидных больных с инсультом. Вестн. восстановительной медицины. 2014; 3: 91. / Rumiantseva S.A., Silina E.V., Orlova A.S., Bolevich S.B. Otsenka reabilitatsionnogo potentsiala u komorbidnykh bol'nykh s insul'tom. Vestn. vosstanovitel'noi meditsiny. 2014; 3: 91. [in Russian]
27. Альжева Н.С., Дьячков А.В., Альжева О.В. Опыт применения мультидисциплинарного подхода в ранней реабилитации больных, перенесших инсульт. Евразийский науч. журн. 2016; 11: 191–3. / Al'zheva N.S., D'iachkov A.V., Al'zheva O.V.Opyt primeneniia mul'tidistsiplinarnogo podkhoda v rannei reabilitatsii bol'nykh, perenesshikh insul't. Evraziiskii nauch. zhurn. 2016; 11: 191–3. [in Russian]
28. Rosales RL, Efendy F, Teleg ES et al. Botulinumtoxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci 2016; 371: 6–14.
29. Hatem SM, Saussez G, Della Faille M et al. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front Hum Neurosci 2016; 10: 442.
30. Акулов М.А., Орлова О.Р., Хатькова С.Е. и др. Электромиографический контроль при проведении инъекций ботулотоксина типа А в мышцы верхней конечности при спастичности различной этиологии. Вопр. нейрохирургии им. Н.Н.Бурденко. 2015; 79 (6): 38–45. / Akulov M.A., Orlova O.R., Khat'kova S.E. i dr. Elektromiograficheskii kontrol' pri provedenii in"ektsii botulotoksina tipa А v myshtsy verkhnei konechnosti pri spastichnosti razlichnoi etiologii. Vopr. neirokhirurgii im. N.N.Burdenko. 2015; 79 (6): 38–45. [in Russian]
31. Baricich A, Carda S, Bertoni M et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 2008; 40: 870–2.
32. Carda S, Invernizzi M, Baricich A, Cisari C. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil 2011; 25: 1119–27.
33. Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther 2009; 26: 241–8.
34. Sun SF, Hsu CW, Sun HP et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010; 24: 34–41.
35. Demetrios M, Khan F, Turner-Stokes L et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013; 6: 9689.
36. Кулишова Т.В., Шинкоренко О.В. Эффективность ранней реабилитации больных с ишемическим инсультом. Вопр. курортологии, физиотерапии и лечебной физической культуры. 2014; 91 (6): 9–12. / Kulishova T.V., Shinkorenko O.V. Effektivnost' rannei reabilitatsii bol'nykh s ishemicheskim insul'tom. Vopr. kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury. 2014; 91 (6): 9–12. [in Russian]
37. Kinoshita S, Momosaki R, Kakuda W et al. Association Between 7 Days Per Week Rehabilitation and Functional Recovery of Patients With Acute Stroke: A Retrospective Cohort Study Based on Japan Rehabilitation Database. Arch Phys Med Rehabil 2016. [Epub ahead of print].
38. Norup A, Guldberg AM, Friis CR et al. An interdisciplinary visual team in an acute and sub-acute stroke unit: Providing assessment and early rehabilitation. Neuro Rehabilitation 2016; 39 (3): 451–61.
39. Pundik S, Falchook AD, McCabe J et al. Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors. Stroke Res Treat 2014; 2014: 306–25.
40. Rathore FA, Wasay M. Acutestroke care and long term rehabilitation in Pakistan: Challenges and solutions. J Pak Med Assoc 2016; 66 (10): 1203–4.
41. Rea M, Rana M, Lugato N et al. Lower Limb Movement Preparation in Chronic Stroke: A Pilot Study Toward an fNIRS-BCI for Gait Rehabilitation. Neurorehabil Neural Repair 2014; 28 (6): 564–75.
42. Srivastava A, Taly AB, Gupta A, Murali T. Rehabilitation interventions to improve locomotor outcome in chronic stroke survivors: A prospective, repeated-measure study. Neurol India 2015; 63 (3): 347–52.
43. Keidel M, Vauth F, Richter J et al. Home-based telerehabilitation after stroke. Nervenarzt 2017; 88 (2): 113–9.
44. Chumbler NR, Li X, Quigley P et al. A randomized controlled trial on Stroke telerehabilitation: The effects on falls self-efficacy and satisfaction with care. J Telemed Telecare 2015; 21 (3): 139–43.
45. Laver KE, Schoene D, Crotty M et al. Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: 102–55.
46. Edgar MC, Monsees S, Rhebergen J et al. Telerehabilitation in Stroke Recovery: A Survey on Access and Willingness to Use Low-Cost Consumer Technologies. Telemed J E Health 2016. [Epub ahead of print].
47. Chen J, Jin W, Zhang XX et al. Telerehabilitation Approaches for Stroke Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis 2015; 24 (12): 2660–8.
48. Rochefolle A, Carré E, Rochefolle A et al. Botulinum toxin prescription in the treatment of spasticity in the neurological rehabilitation service: 2012 to 2015 assessment. Ann Phys Rehabil Med 2016; 59: 143.
2. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31 (5): 535–51.
3. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31 (5): 552–71.
4. Vinti M, Bayle N, Hutin E et al. Stretch-sensitive paresis and effort perception in hemiparesis. J Neural Transm (Vienna) 2015; 122 (8): 1089–97.
5. Gracies JM. Coefficients of impairment in deforming spastic paresis. Ann Phys Rehabil Med 2015; 58 (3): 173–8.
6. Burke D, Gillies JD, Lance JW. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 1970; 33 (2): 216–23.
7. Tardieu G, Shentoub S, Delarue R. Research on a technic for measurement of spasticity. Rev Neurol (Paris) 1954; 91 (2): 143–4.
8. Akulov M.A., Khat'kova S.E., Mokienko O.A. i dr. Effektivnost' botulinoterapii v lechenii spastichnosti verkhnei konechnosti u patsientov s cherepno-mozgovoi travmoi. Zhurn. nevrologii i psikhiatrii im. C.C.Korsakova. 2016; 116 (8): 30–5. [in Russian]
9. Breceda EY, Dromerick AW. Motor rehabilitation in stroke and traumatic brain injury: stimulating and intense. Curr Opin Neurol 2013; 26 (6): 595–601.
10. Simon O, Yelnik AP. Managingspasticity with drugs. Eur J Phys Rehabil Med 2010; 46 (3): 401–10.
11. Sommerfeld DK, Eek EU, Svensson AK et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35 (1): 134–9.
12. Pattuwage L, Olver J, Martin C et al. Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines. J Head Trauma Rehabil 2016. [Epub ahead of print].
13. Wissel J, Verrier M, Simpson DM et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PMR 2015; 7 (1): 60–7.
14. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009; 8 (8): 741–54.
15. Veerbeek JM, van Wegen E, van Peppen R et al. What is the evidence for physical therapy post stroke? A systematic review and meta-analysis. PLoS One 2014; 9 (2): 879–87.
16. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011; 17 (1): 3–10.
17. Sheean G. Botulinum toxin should be first-line treatment for poststroke spasticity. J Neurol Neurosurg Psychiatry 2009; 80 (4): 359.
18. Simpson DM, Hallett M, Ashman EJ et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016; 86 (19): 1818–26.
19. Wissel J, Ward AB, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41 (1): 13–25.
20. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic Literature Review of AboBoNT-A in Clinical Trials for Lower Limb Spasticity. Medicine (Baltimore) 2016; 95 (2): 24–8.
21. Gracies JM, Esquenazi A, Brashear A et al. Poster 288 Efficacy and Safety of Repeated Abobotulinumtoxin A Injections in Adults with Lower Limb Spasticity. PMR 2016; 8 (9): 254.
22. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007; 5: 132–8.
23. Sheean G., McGuire J.R. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PMR 2009; 1: 827–33.
24. Rosales RL, Kong KH, Goh KJ et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair 2012; 26 (7): 812–21.
25. Khat'kova S.E., Akulov M.A., Orlova O.R., Orlova A.S. Sovremennye podkhody k reabilitatsii bol'nykh posle insul'ta. Nervnye bolezni. 2016; 3: 27–33. [in Russian]
26. Rumiantseva S.A., Silina E.V., Orlova A.S., Bolevich S.B. Otsenka reabilitatsionnogo potentsiala u komorbidnykh bol'nykh s insul'tom. Vestn. vosstanovitel'noi meditsiny. 2014; 3: 91. [in Russian]
27. Al'zheva N.S., D'iachkov A.V., Al'zheva O.V.Opyt primeneniia mul'tidistsiplinarnogo podkhoda v rannei reabilitatsii bol'nykh, perenesshikh insul't. Evraziiskii nauch. zhurn. 2016; 11: 191–3. [in Russian]
28. Rosales RL, Efendy F, Teleg ES et al. Botulinumtoxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci 2016; 371: 6–14.
29. Hatem SM, Saussez G, Della Faille M et al. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front Hum Neurosci 2016; 10: 442.
30. Akulov M.A., Orlova O.R., Khat'kova S.E. i dr. Elektromiograficheskii kontrol' pri provedenii in"ektsii botulotoksina tipa А v myshtsy verkhnei konechnosti pri spastichnosti razlichnoi etiologii. Vopr. neirokhirurgii im. N.N.Burdenko. 2015; 79 (6): 38–45. [in Russian]
31. Baricich A, Carda S, Bertoni M et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 2008; 40: 870–2.
32. Carda S, Invernizzi M, Baricich A, Cisari C. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil 2011; 25: 1119–27.
33. Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther 2009; 26: 241–8.
34. Sun SF, Hsu CW, Sun HP et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010; 24: 34–41.
35. Demetrios M, Khan F, Turner-Stokes L et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013; 6: 9689.
36. Kulishova T.V., Shinkorenko O.V. Effektivnost' rannei reabilitatsii bol'nykh s ishemicheskim insul'tom. Vopr. kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury. 2014; 91 (6): 9–12. [in Russian]
37. Kinoshita S, Momosaki R, Kakuda W et al. Association Between 7 Days Per Week Rehabilitation and Functional Recovery of Patients With Acute Stroke: A Retrospective Cohort Study Based on Japan Rehabilitation Database. Arch Phys Med Rehabil 2016. [Epub ahead of print].
38. Norup A, Guldberg AM, Friis CR et al. An interdisciplinary visual team in an acute and sub-acute stroke unit: Providing assessment and early rehabilitation. Neuro Rehabilitation 2016; 39 (3): 451–61.
39. Pundik S, Falchook AD, McCabe J et al. Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors. Stroke Res Treat 2014; 2014: 306–25.
40. Rathore FA, Wasay M. Acutestroke care and long term rehabilitation in Pakistan: Challenges and solutions. J Pak Med Assoc 2016; 66 (10): 1203–4.
41. Rea M, Rana M, Lugato N et al. Lower Limb Movement Preparation in Chronic Stroke: A Pilot Study Toward an fNIRS-BCI for Gait Rehabilitation. Neurorehabil Neural Repair 2014; 28 (6): 564–75.
42. Srivastava A, Taly AB, Gupta A, Murali T. Rehabilitation interventions to improve locomotor outcome in chronic stroke survivors: A prospective, repeated-measure study. Neurol India 2015; 63 (3): 347–52.
43. Keidel M, Vauth F, Richter J et al. Home-based telerehabilitation after stroke. Nervenarzt 2017; 88 (2): 113–9.
44. Chumbler NR, Li X, Quigley P et al. A randomized controlled trial on Stroke telerehabilitation: The effects on falls self-efficacy and satisfaction with care. J Telemed Telecare 2015; 21 (3): 139–43.
45. Laver KE, Schoene D, Crotty M et al. Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: 102–55.
46. Edgar MC, Monsees S, Rhebergen J et al. Telerehabilitation in Stroke Recovery: A Survey on Access and Willingness to Use Low-Cost Consumer Technologies. Telemed J E Health 2016. [Epub ahead of print].
47. Chen J, Jin W, Zhang XX et al. Telerehabilitation Approaches for Stroke Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis 2015; 24 (12): 2660–8.
48. Rochefolle A, Carré E, Rochefolle A et al. Botulinum toxin prescription in the treatment of spasticity in the neurological rehabilitation service: 2012 to 2015 assessment. Ann Phys Rehabil Med 2016; 59: 143.
2. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31 (5): 535–51.
3. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31 (5): 552–71.
4. Vinti M, Bayle N, Hutin E et al. Stretch-sensitive paresis and effort perception in hemiparesis. J Neural Transm (Vienna) 2015; 122 (8): 1089–97.
5. Gracies JM. Coefficients of impairment in deforming spastic paresis. Ann Phys Rehabil Med 2015; 58 (3): 173–8.
6. Burke D, Gillies JD, Lance JW. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 1970; 33 (2): 216–23.
7. Tardieu G, Shentoub S, Delarue R. Research on a technic for measurement of spasticity. Rev Neurol (Paris) 1954; 91 (2): 143–4.
8. Акулов М.А., Хатькова С.Е., Мокиенко О.А. и др. Эффективность ботулинотерапии в лечении спастичности верхней конечности у пациентов с черепно-мозговой травмой. Журн. неврологии и психиатрии им. C.C.Корсакова. 2016; 116 (8): 30–5. / Akulov M.A., Khat'kova S.E., Mokienko O.A. i dr. Effektivnost' botulinoterapii v lechenii spastichnosti verkhnei konechnosti u patsientov s cherepno-mozgovoi travmoi. Zhurn. nevrologii i psikhiatrii im. C.C.Korsakova. 2016; 116 (8): 30–5. [in Russian]
9. Breceda EY, Dromerick AW. Motor rehabilitation in stroke and traumatic brain injury: stimulating and intense. Curr Opin Neurol 2013; 26 (6): 595–601.
10. Simon O, Yelnik AP. Managingspasticity with drugs. Eur J Phys Rehabil Med 2010; 46 (3): 401–10.
11. Sommerfeld DK, Eek EU, Svensson AK et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35 (1): 134–9.
12. Pattuwage L, Olver J, Martin C et al. Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines. J Head Trauma Rehabil 2016. [Epub ahead of print].
13. Wissel J, Verrier M, Simpson DM et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PMR 2015; 7 (1): 60–7.
14. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009; 8 (8): 741–54.
15. Veerbeek JM, van Wegen E, van Peppen R et al. What is the evidence for physical therapy post stroke? A systematic review and meta-analysis. PLoS One 2014; 9 (2): 879–87.
16. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011; 17 (1): 3–10.
17. Sheean G. Botulinum toxin should be first-line treatment for poststroke spasticity. J Neurol Neurosurg Psychiatry 2009; 80 (4): 359.
18. Simpson DM, Hallett M, Ashman EJ et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016; 86 (19): 1818–26.
19. Wissel J, Ward AB, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41 (1): 13–25.
20. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic Literature Review of AboBoNT-A in Clinical Trials for Lower Limb Spasticity. Medicine (Baltimore) 2016; 95 (2): 24–8.
21. Gracies JM, Esquenazi A, Brashear A et al. Poster 288 Efficacy and Safety of Repeated Abobotulinumtoxin A Injections in Adults with Lower Limb Spasticity. PMR 2016; 8 (9): 254.
22. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007; 5: 132–8.
23. Sheean G., McGuire J.R. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PMR 2009; 1: 827–33.
24. Rosales RL, Kong KH, Goh KJ et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair 2012; 26 (7): 812–21.
25. Хатькова С.Е., Акулов М.А., Орлова О.Р., Орлова А.С. Современные подходы к реабилитации больных после инсульта. Нервные болезни. 2016; 3: 27–33. / Khat'kova S.E., Akulov M.A., Orlova O.R., Orlova A.S. Sovremennye podkhody k reabilitatsii bol'nykh posle insul'ta. Nervnye bolezni. 2016; 3: 27–33. [in Russian]
26. Румянцева С.А., Силина Е.В., Орлова А.С., Болевич С.Б. Оценка реабилитационного потенциала у коморбидных больных с инсультом. Вестн. восстановительной медицины. 2014; 3: 91. / Rumiantseva S.A., Silina E.V., Orlova A.S., Bolevich S.B. Otsenka reabilitatsionnogo potentsiala u komorbidnykh bol'nykh s insul'tom. Vestn. vosstanovitel'noi meditsiny. 2014; 3: 91. [in Russian]
27. Альжева Н.С., Дьячков А.В., Альжева О.В. Опыт применения мультидисциплинарного подхода в ранней реабилитации больных, перенесших инсульт. Евразийский науч. журн. 2016; 11: 191–3. / Al'zheva N.S., D'iachkov A.V., Al'zheva O.V.Opyt primeneniia mul'tidistsiplinarnogo podkhoda v rannei reabilitatsii bol'nykh, perenesshikh insul't. Evraziiskii nauch. zhurn. 2016; 11: 191–3. [in Russian]
28. Rosales RL, Efendy F, Teleg ES et al. Botulinumtoxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci 2016; 371: 6–14.
29. Hatem SM, Saussez G, Della Faille M et al. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front Hum Neurosci 2016; 10: 442.
30. Акулов М.А., Орлова О.Р., Хатькова С.Е. и др. Электромиографический контроль при проведении инъекций ботулотоксина типа А в мышцы верхней конечности при спастичности различной этиологии. Вопр. нейрохирургии им. Н.Н.Бурденко. 2015; 79 (6): 38–45. / Akulov M.A., Orlova O.R., Khat'kova S.E. i dr. Elektromiograficheskii kontrol' pri provedenii in"ektsii botulotoksina tipa А v myshtsy verkhnei konechnosti pri spastichnosti razlichnoi etiologii. Vopr. neirokhirurgii im. N.N.Burdenko. 2015; 79 (6): 38–45. [in Russian]
31. Baricich A, Carda S, Bertoni M et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 2008; 40: 870–2.
32. Carda S, Invernizzi M, Baricich A, Cisari C. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil 2011; 25: 1119–27.
33. Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther 2009; 26: 241–8.
34. Sun SF, Hsu CW, Sun HP et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010; 24: 34–41.
35. Demetrios M, Khan F, Turner-Stokes L et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013; 6: 9689.
36. Кулишова Т.В., Шинкоренко О.В. Эффективность ранней реабилитации больных с ишемическим инсультом. Вопр. курортологии, физиотерапии и лечебной физической культуры. 2014; 91 (6): 9–12. / Kulishova T.V., Shinkorenko O.V. Effektivnost' rannei reabilitatsii bol'nykh s ishemicheskim insul'tom. Vopr. kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury. 2014; 91 (6): 9–12. [in Russian]
37. Kinoshita S, Momosaki R, Kakuda W et al. Association Between 7 Days Per Week Rehabilitation and Functional Recovery of Patients With Acute Stroke: A Retrospective Cohort Study Based on Japan Rehabilitation Database. Arch Phys Med Rehabil 2016. [Epub ahead of print].
38. Norup A, Guldberg AM, Friis CR et al. An interdisciplinary visual team in an acute and sub-acute stroke unit: Providing assessment and early rehabilitation. Neuro Rehabilitation 2016; 39 (3): 451–61.
39. Pundik S, Falchook AD, McCabe J et al. Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors. Stroke Res Treat 2014; 2014: 306–25.
40. Rathore FA, Wasay M. Acutestroke care and long term rehabilitation in Pakistan: Challenges and solutions. J Pak Med Assoc 2016; 66 (10): 1203–4.
41. Rea M, Rana M, Lugato N et al. Lower Limb Movement Preparation in Chronic Stroke: A Pilot Study Toward an fNIRS-BCI for Gait Rehabilitation. Neurorehabil Neural Repair 2014; 28 (6): 564–75.
42. Srivastava A, Taly AB, Gupta A, Murali T. Rehabilitation interventions to improve locomotor outcome in chronic stroke survivors: A prospective, repeated-measure study. Neurol India 2015; 63 (3): 347–52.
43. Keidel M, Vauth F, Richter J et al. Home-based telerehabilitation after stroke. Nervenarzt 2017; 88 (2): 113–9.
44. Chumbler NR, Li X, Quigley P et al. A randomized controlled trial on Stroke telerehabilitation: The effects on falls self-efficacy and satisfaction with care. J Telemed Telecare 2015; 21 (3): 139–43.
45. Laver KE, Schoene D, Crotty M et al. Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: 102–55.
46. Edgar MC, Monsees S, Rhebergen J et al. Telerehabilitation in Stroke Recovery: A Survey on Access and Willingness to Use Low-Cost Consumer Technologies. Telemed J E Health 2016. [Epub ahead of print].
47. Chen J, Jin W, Zhang XX et al. Telerehabilitation Approaches for Stroke Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis 2015; 24 (12): 2660–8.
48. Rochefolle A, Carré E, Rochefolle A et al. Botulinum toxin prescription in the treatment of spasticity in the neurological rehabilitation service: 2012 to 2015 assessment. Ann Phys Rehabil Med 2016; 59: 143.
________________________________________________
2. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31 (5): 535–51.
3. Gracies JM. Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve 2005; 31 (5): 552–71.
4. Vinti M, Bayle N, Hutin E et al. Stretch-sensitive paresis and effort perception in hemiparesis. J Neural Transm (Vienna) 2015; 122 (8): 1089–97.
5. Gracies JM. Coefficients of impairment in deforming spastic paresis. Ann Phys Rehabil Med 2015; 58 (3): 173–8.
6. Burke D, Gillies JD, Lance JW. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry 1970; 33 (2): 216–23.
7. Tardieu G, Shentoub S, Delarue R. Research on a technic for measurement of spasticity. Rev Neurol (Paris) 1954; 91 (2): 143–4.
8. Akulov M.A., Khat'kova S.E., Mokienko O.A. i dr. Effektivnost' botulinoterapii v lechenii spastichnosti verkhnei konechnosti u patsientov s cherepno-mozgovoi travmoi. Zhurn. nevrologii i psikhiatrii im. C.C.Korsakova. 2016; 116 (8): 30–5. [in Russian]
9. Breceda EY, Dromerick AW. Motor rehabilitation in stroke and traumatic brain injury: stimulating and intense. Curr Opin Neurol 2013; 26 (6): 595–601.
10. Simon O, Yelnik AP. Managingspasticity with drugs. Eur J Phys Rehabil Med 2010; 46 (3): 401–10.
11. Sommerfeld DK, Eek EU, Svensson AK et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 2004; 35 (1): 134–9.
12. Pattuwage L, Olver J, Martin C et al. Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines. J Head Trauma Rehabil 2016. [Epub ahead of print].
13. Wissel J, Verrier M, Simpson DM et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PMR 2015; 7 (1): 60–7.
14. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. Lancet Neurol 2009; 8 (8): 741–54.
15. Veerbeek JM, van Wegen E, van Peppen R et al. What is the evidence for physical therapy post stroke? A systematic review and meta-analysis. PLoS One 2014; 9 (2): 879–87.
16. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011; 17 (1): 3–10.
17. Sheean G. Botulinum toxin should be first-line treatment for poststroke spasticity. J Neurol Neurosurg Psychiatry 2009; 80 (4): 359.
18. Simpson DM, Hallett M, Ashman EJ et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016; 86 (19): 1818–26.
19. Wissel J, Ward AB, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41 (1): 13–25.
20. Dashtipour K, Chen JJ, Walker HW, Lee MY. Systematic Literature Review of AboBoNT-A in Clinical Trials for Lower Limb Spasticity. Medicine (Baltimore) 2016; 95 (2): 24–8.
21. Gracies JM, Esquenazi A, Brashear A et al. Poster 288 Efficacy and Safety of Repeated Abobotulinumtoxin A Injections in Adults with Lower Limb Spasticity. PMR 2016; 8 (9): 254.
22. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007; 5: 132–8.
23. Sheean G., McGuire J.R. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification. PMR 2009; 1: 827–33.
24. Rosales RL, Kong KH, Goh KJ et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair 2012; 26 (7): 812–21.
25. Khat'kova S.E., Akulov M.A., Orlova O.R., Orlova A.S. Sovremennye podkhody k reabilitatsii bol'nykh posle insul'ta. Nervnye bolezni. 2016; 3: 27–33. [in Russian]
26. Rumiantseva S.A., Silina E.V., Orlova A.S., Bolevich S.B. Otsenka reabilitatsionnogo potentsiala u komorbidnykh bol'nykh s insul'tom. Vestn. vosstanovitel'noi meditsiny. 2014; 3: 91. [in Russian]
27. Al'zheva N.S., D'iachkov A.V., Al'zheva O.V.Opyt primeneniia mul'tidistsiplinarnogo podkhoda v rannei reabilitatsii bol'nykh, perenesshikh insul't. Evraziiskii nauch. zhurn. 2016; 11: 191–3. [in Russian]
28. Rosales RL, Efendy F, Teleg ES et al. Botulinumtoxin as early intervention for spasticity after stroke or non-progressive brain lesion: A meta-analysis. J Neurol Sci 2016; 371: 6–14.
29. Hatem SM, Saussez G, Della Faille M et al. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front Hum Neurosci 2016; 10: 442.
30. Akulov M.A., Orlova O.R., Khat'kova S.E. i dr. Elektromiograficheskii kontrol' pri provedenii in"ektsii botulotoksina tipa А v myshtsy verkhnei konechnosti pri spastichnosti razlichnoi etiologii. Vopr. neirokhirurgii im. N.N.Burdenko. 2015; 79 (6): 38–45. [in Russian]
31. Baricich A, Carda S, Bertoni M et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 2008; 40: 870–2.
32. Carda S, Invernizzi M, Baricich A, Cisari C. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil 2011; 25: 1119–27.
33. Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study. Adv Ther 2009; 26: 241–8.
34. Sun SF, Hsu CW, Sun HP et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010; 24: 34–41.
35. Demetrios M, Khan F, Turner-Stokes L et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013; 6: 9689.
36. Kulishova T.V., Shinkorenko O.V. Effektivnost' rannei reabilitatsii bol'nykh s ishemicheskim insul'tom. Vopr. kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury. 2014; 91 (6): 9–12. [in Russian]
37. Kinoshita S, Momosaki R, Kakuda W et al. Association Between 7 Days Per Week Rehabilitation and Functional Recovery of Patients With Acute Stroke: A Retrospective Cohort Study Based on Japan Rehabilitation Database. Arch Phys Med Rehabil 2016. [Epub ahead of print].
38. Norup A, Guldberg AM, Friis CR et al. An interdisciplinary visual team in an acute and sub-acute stroke unit: Providing assessment and early rehabilitation. Neuro Rehabilitation 2016; 39 (3): 451–61.
39. Pundik S, Falchook AD, McCabe J et al. Functional Brain Correlates of Upper Limb Spasticity and Its Mitigation following Rehabilitation in Chronic Stroke Survivors. Stroke Res Treat 2014; 2014: 306–25.
40. Rathore FA, Wasay M. Acutestroke care and long term rehabilitation in Pakistan: Challenges and solutions. J Pak Med Assoc 2016; 66 (10): 1203–4.
41. Rea M, Rana M, Lugato N et al. Lower Limb Movement Preparation in Chronic Stroke: A Pilot Study Toward an fNIRS-BCI for Gait Rehabilitation. Neurorehabil Neural Repair 2014; 28 (6): 564–75.
42. Srivastava A, Taly AB, Gupta A, Murali T. Rehabilitation interventions to improve locomotor outcome in chronic stroke survivors: A prospective, repeated-measure study. Neurol India 2015; 63 (3): 347–52.
43. Keidel M, Vauth F, Richter J et al. Home-based telerehabilitation after stroke. Nervenarzt 2017; 88 (2): 113–9.
44. Chumbler NR, Li X, Quigley P et al. A randomized controlled trial on Stroke telerehabilitation: The effects on falls self-efficacy and satisfaction with care. J Telemed Telecare 2015; 21 (3): 139–43.
45. Laver KE, Schoene D, Crotty M et al. Telerehabilitation services for stroke. Cochrane Database Syst Rev 2013; 12: 102–55.
46. Edgar MC, Monsees S, Rhebergen J et al. Telerehabilitation in Stroke Recovery: A Survey on Access and Willingness to Use Low-Cost Consumer Technologies. Telemed J E Health 2016. [Epub ahead of print].
47. Chen J, Jin W, Zhang XX et al. Telerehabilitation Approaches for Stroke Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis 2015; 24 (12): 2660–8.
48. Rochefolle A, Carré E, Rochefolle A et al. Botulinum toxin prescription in the treatment of spasticity in the neurological rehabilitation service: 2012 to 2015 assessment. Ann Phys Rehabil Med 2016; 59: 143.
Авторы
С.Е.Хатькова*1,2, М.А.Акулов3, Д.Ю.Усачев3, А.Ю.Боцина4, Р.К.Шихкеримов5, А.С.Орлова6
1 ФГАУ «Лечебно-реабилитационный центр» Минздрава России. 125367, Россия, Москва, Иваньковское ш., д. 3;
2 ФГБУ ГНЦ «Федеральный медицинский биофизический центр им. А.И.Бурназяна» ФМБА России. 123058, Россия, Москва, ул. Маршала Новикова, д. 23;
3 ФГАУ «Национальный научно-практический центр нейрохирургии им. акад. Н.Н.Бурденко» Минздрава России. 125047, Россия, Москва, ул. 4-я Тверская-Ямская, д. 16;
4 ГБУЗ «Городская клиническая больница им. И.В.Давыдовского» Департамента здравоохранения г. Москвы. 109240, Россия, Москва, ул. Яузская, д. 11;
5 ГБУЗ «Городская поликлиника №166» Департамента здравоохранения г. Москвы. 115551, Россия, Москва, Домодедовская ул., д. 9;
6 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*hse15@mail.ru
1 Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation. 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3;
2 A.I.Burnazian Federal Medical Biophysical Center. 123058, Russian Federation, Moscow, ul. Marshala Novikova, d. 23;
3 N.N.Burdenko National Scientific and Practical Center of Neurosurgery. 125047, Russian Federation, Moscow, ul. 4-ia Tverskaia-Iamskaia, d. 16;
4 I.V.Davydovskii City Clinical Hospital of the Department of Health of Moscow. 109240, Russian Federation, Moscow, ul. Iauzskaia, d. 11;
5 City Clinical Hospital №166 of the Department of Health of Moscow. 115551, Russian Federation, Moscow, Domodedovskaia ul., d. 9;
6 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaya, d. 8, str. 2
*hse15@mail.ru
1 ФГАУ «Лечебно-реабилитационный центр» Минздрава России. 125367, Россия, Москва, Иваньковское ш., д. 3;
2 ФГБУ ГНЦ «Федеральный медицинский биофизический центр им. А.И.Бурназяна» ФМБА России. 123058, Россия, Москва, ул. Маршала Новикова, д. 23;
3 ФГАУ «Национальный научно-практический центр нейрохирургии им. акад. Н.Н.Бурденко» Минздрава России. 125047, Россия, Москва, ул. 4-я Тверская-Ямская, д. 16;
4 ГБУЗ «Городская клиническая больница им. И.В.Давыдовского» Департамента здравоохранения г. Москвы. 109240, Россия, Москва, ул. Яузская, д. 11;
5 ГБУЗ «Городская поликлиника №166» Департамента здравоохранения г. Москвы. 115551, Россия, Москва, Домодедовская ул., д. 9;
6 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М.Сеченова» Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*hse15@mail.ru
________________________________________________
1 Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation. 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3;
2 A.I.Burnazian Federal Medical Biophysical Center. 123058, Russian Federation, Moscow, ul. Marshala Novikova, d. 23;
3 N.N.Burdenko National Scientific and Practical Center of Neurosurgery. 125047, Russian Federation, Moscow, ul. 4-ia Tverskaia-Iamskaia, d. 16;
4 I.V.Davydovskii City Clinical Hospital of the Department of Health of Moscow. 109240, Russian Federation, Moscow, ul. Iauzskaia, d. 11;
5 City Clinical Hospital №166 of the Department of Health of Moscow. 115551, Russian Federation, Moscow, Domodedovskaia ul., d. 9;
6 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaya, d. 8, str. 2
*hse15@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.